One of the exoskeleton stocks I discussed in this week’s issue of Breakthrough Tech Weekly, Ekso Bionics (EKSO), announced a 1:7 reverse stock split effective immediately so it can begin trading on the more liquid NASDAQ Capital Market exchange. This transaction will have the effect of increasing Ekso’s share price seven-fold, while reducing the number of shares outstanding by the same amount. The stock will trade under the symbol EKSOD for twenty days to help avoid confusion over the much higher price. If you use the old symbol of EKSO you will see a share price of $0.85, but no trading history beyond May 4th. If you are a current shareholder of EKSO you do not need to do anything for this conversion to be made in your account; it will happen automatically at your broker, and is not a taxable event. 

We believe this is one more positive sign that the exoskeleton industry is rapidly gaining acceptance, and may soon increase significantly in value. We suggest that investors wishing to participate in this high-risk/high-reward growth market buy both Ekso Bionics (EKSOD) and ReWalk Robotics (RWLK).